Deals
Dassault to Buy Medidata in $5.7 Billion Health Data Push
- Biggest deal yet for industrial design software specialist
- Medidata analyzes clinical trials for world’s top drugmakers
This article is for subscribers only.
Dassault Systemes SE, a maker of industrial design software, agreed to buy Medidata Solutions Inc. for $5.7 billion to gain a foothold in the fast-growing market for clinical trial technology.
The deal pushes the French company further beyond its design roots into data processing and business analysis. Medidata’s software analyzes pharmaceutical and biotech trials for some of the world’s biggest drugmakers including Sanofi SA, Pfizer Inc. and AstraZeneca Plc.